The global prevalence of 537 million affected in the age group of 2079 years in 2021 will rise to 783 million in 2045, with the lowest increase in incidence in Europe (13%) and the highest in the African countries south of the Sahara (134%) (1)
Fatigue and energy changes Some people experience fatigue on GLP-1 medications , especially during the first few weeks
Furthermore, we approached both Netherlands Pharmacovigilance Centre Lareb on 17 January 2023 and the Teratology Information Service (TIS) of Switzerland on 6 February 2023 for any pregnancy outcomes of women exposed to either GLP-1 agonists or SGLT2 inhibitors during pregnancy available to them
For medications with short half-lives, steady state can happen in just a few days
As GLP-1s can cross the blood-brain barrier and have a direct effect on brain function, it is important to examine their impact on mental health, especially in patients with mental illness. Researchers conducted a systematic review of studies assessing the impact of GLP-1s on mental health and metabolic outcomes in people with and without a mental illness between 2010 and August 2024
Theres a smarter, science-backed way to restore volume and bounce to your skin